Novel Pickering emulsion gels stabilized solely by phenylalanine amidated pectin: Characterization, stability and curcumin bioaccessibility

C Zheng, Y Huang, X Liang, B Shen, G Zhang… - International Journal of …, 2023 - Elsevier
Pickering emulsion gels represent a novel class of non-toxic and biocompatible emulsions,
offering extensive applications in the pharmaceutical and food additive sectors. This study …

Association between periodontitis and hypertension: cross-sectional survey from the Fourth National Oral Health Survey of China (2015–2016)

Y Zhan, J Jiao, W Jing, X Feng, B Tai, D Hu, H Lin… - BMJ open, 2023 - bmjopen.bmj.com
Objectives To evaluate the association between periodontitis severity and hypertension
based on Chinese epidemiological data. Design This cross-sectional survey enrolled adults …

Paclitaxel exposure: long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials

PA Schneider, M Brodmann, L Mauri… - Catheterization and …, 2020 - Wiley Online Library
Background Paclitaxel drug‐coated balloons (DCB) prevent recurrent claudication after
angioplasty, yet data from randomized trials with incomplete follow‐up have raised …

Long-term outcomes of the 150 mm drug-coated balloon cohort from the IN. PACT Global Study

M Brodmann, W Lansink, K Guetl, A Micari… - CardioVascular and …, 2022 - Springer
Purpose Data on the long-term safety and effectiveness of drug-coated balloons (DCBs) for
the treatment of long femoropopliteal atherosclerotic lesions in the real-world setting are …

[HTML][HTML] Four-year patient-level pooled mortality analysis of the ILLUMENATE US Pivotal and EU randomized controlled trials

SP Lyden, M Brodmann, SA Parikh, P Krishnan… - Journal of Vascular …, 2022 - Elsevier
Objective To perform a meta-analysis of two concordant randomized controlled trials (RCTs)
examining the long-term, 4-year safety profile of the Stellarex drug-coated balloon (DCB) vs …

[HTML][HTML] Outcome after revascularization with paclitaxel-coated devices in patients with chronic limb-threatening ischemia

JA Smith, KL So, VS Kashyap, JS Cho… - Journal of Vascular …, 2023 - Elsevier
Objective Data regarding the safety and efficacy of paclitaxel (PTX)-coated peripheral
arterial devices for femoropopliteal artery (FPA) atherosclerotic disease is derived from …

[HTML][HTML] Drug-coated balloons in the neurovascular setting: a comprehensive, systematic review of current use and indications

P von Gottberg, A Cimpoca, C Wendl… - Reviews in …, 2022 - imrpress.com
Background: Drug-coated balloons (DCB) are an established tool in the prevention and
treatment of coronary and peripheral artery restenosis. The underlying effects of restenosis …

Assessment of mortality and factors affecting outcome of use of paclitaxel-coated stents and bare metal stents in femoropopliteal PAD

A Falkowski, H Bogacki, M Szemitko - Journal of Clinical Medicine, 2020 - mdpi.com
The use of drug-coated devices in intravascular therapy is aimed at preventing neointimal
hyperplasia caused by excessive proliferation of vascular smooth muscle and thereby …

Twelve-Month results from the first-in-China prospective, multi-center, randomized, controlled study of the FREEWAY paclitaxel-coated balloon for femoropopliteal …

B Zhang, M Yang, T He, X Li, J Gu, X Zhang… - Frontiers in …, 2021 - frontiersin.org
Background: Several paclitaxel-coated balloons have been proved to provide better efficacy
results than uncoated balloons in femoropopliteal lesions. But the efficacy and safety of …

[HTML][HTML] Paclitaxel-coated peripheral arterial devices are associated with improved overall survival and limb salvage in patients with chronic limb-threatening ischemia

NH Kumins, AH King, RN Ambani, JS Cho… - Journal of Vascular …, 2021 - Elsevier
Objective Paclitaxel (PTX)-coated peripheral arterial devices have been shown to decrease
femoropopliteal artery restenosis and the need for reintervention compared with non-PTX …